Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The possibility that measuring blood natriuretic peptide concentrations
could identify patients with left ventricular systolic dysfunction
without echocardiography has attracted interest. The peptides are
stable and can be assayed easily. McClure et al (p 516) tested the
value of brain and N-terminal atrial natriuretic peptides in identifying patients with left ventricular dysfunction among a general practice cohort of 134 stable, long term survivors of
myocardial infarction. Although brain natriuretic peptide (but not
N-terminal atrial natriuretic peptide) was able to
discriminate between severe left systolic ventricular dysfunction and
preserved function, it could not discriminate between lesser degrees of dysfunction and normal.